Pidotimod – Current Role and Evidence
Recurrent respiratory infections (RRIs) are common in the pediatric age group and in patients with chronic respiratory disorders, leading to frequent hospitalization and poorer quality of life. Studies have shown that an immature immune system in childhood can predispose to RRIs, leading to adult li...
Saved in:
| Main Authors: | Yash Sanjay Kedia, Pranav Ish, Vidushi Rathi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-11-01
|
| Series: | Journal of Advanced Lung Health |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jalh.jalh_36_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN
by: G. Caramia, et al.
Published: (2008-04-01) -
PIDOTIMOD IN TREATMENT OF CHILDREN WITH ACUTE RESPIRATORY INFECTION WITH CONCOMITANT RECURRENT OBSTRUCTIVE SYNDROME
by: E. E. Lokshina, et al.
Published: (2011-01-01) -
APPLICATION OF PIDOTIMOD FOR OFTEN RESPIRATORY INFECTIONS PROPHYLAXIS IN CHILDREN WITH ALLERGIC RESPIRATORY DISEASES
by: I. M. Gaiduk, et al.
Published: (2012-09-01) -
Pidotimod alleviated experimental autoimmune encephalomyelitis by regulating the balance of splenic lymphocytes
by: Yanping Wang, et al.
Published: (2025-07-01) -
Erdosteine in Chronic Obstructive Pulmonary Disease – Evidence and Current Role
by: Yash Kedia, et al.
Published: (2024-11-01)